ARBUTUS BIOPHARMA CORP's ticker is ABUS and the CUSIP is 03879J100. A total of 55 filers reported holding ARBUTUS BIOPHARMA CORP in Q4 2016. The put-call ratio across all filers is 9.10 and the average weighting 0.1%.
Quarter-by-quarter ownership
Value | Shares | Weighting | ||||
---|---|---|---|---|---|---|
Q2 2024 | $1,099,920 | +26.1% | 354,813 | +6.1% | 0.00% | – |
Q1 2024 | $872,431 | -2.5% | 334,265 | -5.1% | 0.00% | – |
Q4 2023 | $894,753 | +36.3% | 352,265 | +10.0% | 0.00% | – |
Q3 2023 | $656,377 | -38.4% | 320,184 | -25.2% | 0.00% | – |
Q2 2023 | $1,066,400 | +8.7% | 428,273 | +34.9% | 0.00% | – |
Q1 2023 | $981,221 | +23.7% | 317,455 | -0.7% | 0.00% | – |
Q4 2022 | $793,086 | +12.2% | 319,793 | -0.1% | 0.00% | – |
Q3 2022 | $707,000 | -18.6% | 320,003 | -2.6% | 0.00% | – |
Q2 2022 | $869,000 | -8.8% | 328,462 | +3.1% | 0.00% | – |
Q1 2022 | $953,000 | +3.5% | 318,580 | +34.5% | 0.00% | – |
Q4 2021 | $921,000 | +1.2% | 236,858 | +11.4% | 0.00% | – |
Q3 2021 | $910,000 | +14.3% | 212,561 | -15.7% | 0.00% | – |
Q2 2021 | $796,000 | -9.9% | 252,041 | -6.1% | 0.00% | -100.0% |
Q1 2021 | $883,000 | -45.6% | 268,388 | -28.5% | 0.00% | 0.0% |
Q4 2020 | $1,622,000 | +30.2% | 375,513 | -7.5% | 0.00% | 0.0% |
Q3 2020 | $1,246,000 | +43.7% | 406,015 | -12.9% | 0.00% | 0.0% |
Q2 2020 | $867,000 | +53.2% | 465,966 | -17.6% | 0.00% | 0.0% |
Q1 2020 | $566,000 | -71.6% | 565,522 | -21.2% | 0.00% | 0.0% |
Q4 2019 | $1,994,000 | +29.8% | 717,250 | -28.8% | 0.00% | 0.0% |
Q3 2019 | $1,536,000 | -29.6% | 1,007,215 | -4.0% | 0.00% | -50.0% |
Q2 2019 | $2,182,000 | -37.7% | 1,049,006 | +7.1% | 0.00% | -33.3% |
Q1 2019 | $3,505,000 | -5.4% | 979,124 | +1.2% | 0.00% | -25.0% |
Q4 2018 | $3,706,000 | -56.9% | 967,604 | +6.3% | 0.00% | -42.9% |
Q3 2018 | $8,601,000 | +24.7% | 910,206 | -3.7% | 0.01% | +16.7% |
Q2 2018 | $6,897,000 | +56.3% | 944,764 | +7.1% | 0.01% | +50.0% |
Q1 2018 | $4,412,000 | +1.2% | 882,423 | +2.2% | 0.00% | 0.0% |
Q4 2017 | $4,360,000 | -17.6% | 863,397 | +1.1% | 0.00% | -20.0% |
Q3 2017 | $5,294,000 | +68.2% | 853,929 | -2.3% | 0.01% | +66.7% |
Q2 2017 | $3,147,000 | +12.9% | 874,254 | +1.9% | 0.00% | 0.0% |
Q1 2017 | $2,788,000 | +18.8% | 857,719 | -3.1% | 0.00% | +50.0% |
Q4 2016 | $2,346,000 | -20.9% | 885,197 | +2.7% | 0.00% | -33.3% |
Q3 2016 | $2,964,000 | +5.0% | 861,553 | +6.3% | 0.00% | 0.0% |
Q2 2016 | $2,822,000 | -14.1% | 810,785 | +1.9% | 0.00% | -25.0% |
Q1 2016 | $3,285,000 | -4.1% | 795,335 | +3.3% | 0.00% | 0.0% |
Q4 2015 | $3,425,000 | – | 769,770 | – | 0.00% | – |
Download |
Other shareholders
Name | Shares | Value | Weighting ↓ |
---|---|---|---|
Foresite Capital Management IV, LLC | 2,651,825 | $19,358,000 | 6.60% |
RTW INVESTMENTS, LP | 5,165,499 | $37,708,000 | 2.72% |
Eversept Partners, LP | 97,495 | $711,714 | 0.33% |
Seelaus Asset Management LLC | 14,300 | $104,000 | 0.09% |
LADENBURG THALMANN FINANCIAL SERVICES INC. | 1,765,315 | $8,827,000 | 0.08% |
ALGERT GLOBAL LLC | 34,816 | $254,000 | 0.05% |
BOOTHBAY FUND MANAGEMENT, LLC | 48,000 | $350,000 | 0.03% |
OXFORD ASSET MANAGEMENT LLP | 211,115 | $1,540,000 | 0.03% |
PRIMECAP MANAGEMENT CO/CA/ | 4,000,400 | $29,203,000 | 0.02% |
PDT Partners, LLC | 66,965 | $489,000 | 0.02% |